R1 Therapeutics raises $77.5M in Series A funding to advance its innovative therapies.
Amount Raised
$77.5 Million
Round Type
Series A
Investors
Description
R1 Therapeutics has successfully raised $77.5 million in a Series A funding round. The funds will be utilized to further develop its innovative therapeutic solutions. This investment will help support the company's ongoing research and development initiatives.
Quick answer
R1 Therapeutics raised $77.5 Million in a Series A round, dated March 17, 2026. Investors: Symbiosis, DaVita Venture Group, F Prime Capital and Abingworth.
- How much did R1 Therapeutics raise?
- R1 Therapeutics raised $77.5 Million in a Series A round on March 17, 2026.
- Who invested in R1 Therapeutics?
- Symbiosis, DaVita Venture Group, F Prime Capital and Abingworth are named as investors in this round.
- What does R1 Therapeutics do?
- R1 Therapeutics is a biotechnology company focused on developing innovative therapeutics.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as R1 Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- mbiomics raised $35M (Series A) on April 29, 2026.
- Coultreon Biopharma raised $125M (Series A) on April 28, 2026.
- NewcelX raised $3.4M on April 27, 2026.
- Lighthouse Pharmaceuticals raised $15M (Series A) on April 22, 2026.
- Tortugas Neuroscience raised $106M (Series A) on April 21, 2026.
- Beeline Medicines raised $300M (Series A) on April 16, 2026.
Who to call at R1 Therapeutics, and when
A new round usually means R1 Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day R1 Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at R1 Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at R1 Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment R1 Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansR1 Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.